{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["autoimmune diseases", "inflammatory diseases", "rheumatoid arthritis", "sinomenine", "traditional Chinese medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36557779", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "07"}], "Language": ["eng"], "ELocationID": ["8645", "10.3390/molecules27248645"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "24", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "07"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Towards Better Sinomenine-Type Drugs to Treat Rheumatoid Arthritis: Molecular Mechanisms and Structural Modification.", "Abstract": {"AbstractText": ["Sinomenine is the main component of the vine <i>Sinomenium acutum</i>. It was first isolated in the early 1920s and has since attracted special interest as a potential anti-rheumatoid arthritis (RA) agent, owing to its successful application in traditional Chinese medicine for the treatment of neuralgia and rheumatoid diseases. In the past few decades, significant advances have broadened our understanding of the molecular mechanisms through which sinomenine treats RA, as well as the structural modifications necessary for improved pharmacological activity. In this review, we summarize up-to-date reports on the pharmacological properties of sinomenine in RA treatment, document their underlying mechanisms, and provide an overview of promising sinomenine derivatives as potential RA drug therapies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Huanghe Science and Technology College, Zhengzhou 450006, China."}], "LastName": "Zhang", "ForeName": "Cuili", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Zhang", "ForeName": "Shujie", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Liao", "ForeName": "Jingjing", "Initials": "J"}, {"Identifier": ["0000-0003-2074-9476"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Chai", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Huanghe Science and Technology College, Zhengzhou 450006, China."}, {"Identifier": [], "Affiliation": "Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China."}], "LastName": "Lyu", "ForeName": "Haining", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "63LT81K70N", "NameOfSubstance": "sinomenine"}, {"RegistryNumber": "0", "NameOfSubstance": "Morphinans"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": ["therapeutic use", "pharmacology"], "DescriptorName": "Morphinans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neuralgia"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sparks J.A. Rheumatoid arthritis. Ann. Intern. Med. 2019;170:ITC1\u2013ITC16. doi: 10.7326/AITC201901010.", "ArticleIdList": ["10.7326/AITC201901010", "30596879"]}, {"Citation": "Aletaha D., Smolen J.S. Diagnosis and management of rheumatoid arthritis: A review. JAMA. 2018;320:1360\u20131372. doi: 10.1001/jama.2018.13103.", "ArticleIdList": ["10.1001/jama.2018.13103", "30285183"]}, {"Citation": "Weyand C.M., Goronzy J.J. The immunology of rheumatoid arthritis. Nat. Immunol. 2021;22:10\u201318. doi: 10.1038/s41590-020-00816-x.", "ArticleIdList": ["10.1038/s41590-020-00816-x", "PMC8557973", "33257900"]}, {"Citation": "Tripathy A., Swain N., Gupta B. Understanding the role and uses of alternative therapies for the management of rheumatoid arthritis. Curr. Rheumatol. Rev. 2022;18:89\u2013100. doi: 10.2174/1573397117666211116102454.", "ArticleIdList": ["10.2174/1573397117666211116102454", "34784872"]}, {"Citation": "Zhao X.X., Peng C., Zhang H., Qin L.P. Sinomenium acutum: A review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm. Biol. 2012;50:1053\u20131061. doi: 10.3109/13880209.2012.656847.", "ArticleIdList": ["10.3109/13880209.2012.656847", "22775422"]}, {"Citation": "Ishiwari N. An alkaloid of Sinomenium diversifolius. Chugai Iji Shimpo. 1920;959:277\u2013296."}, {"Citation": "Zhang M.W., Wang X.H., Shi J., Yu J.G. Sinomenine in cardio-cerebrovascular diseases: Potential therapeutic effects and pharmacological evidences. Front. Cardiovasc. Med. 2021;8:749113. doi: 10.3389/fcvm.2021.749113.", "ArticleIdList": ["10.3389/fcvm.2021.749113", "PMC8517137", "34660748"]}, {"Citation": "Jiang W., Fan W., Gao T., Li T., Yin Z., Guo H., Wang L., Han Y., Jiang J.D. Analgesic mechanism of sinomenine against chronic pain. Pain Res. Manag. 2020;2020:1876862. doi: 10.1155/2020/1876862.", "ArticleIdList": ["10.1155/2020/1876862", "PMC7225909", "32454918"]}, {"Citation": "Huang R.Y., Pan H.D., Wu J.Q., Zhou H., Li Z.G., Qiu P., Zhou Y.Y., Chen X.M., Xie Z.X., Xiao Y., et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial. Phytomedicine. 2019;57:403\u2013410. doi: 10.1016/j.phymed.2018.12.030.", "ArticleIdList": ["10.1016/j.phymed.2018.12.030", "30851515"]}, {"Citation": "Wang Q., Li X.K. Immunosuppressive and anti-inflammatory activities of sinomenine. Int. Immunopharmacol. 2011;11:373\u2013376. doi: 10.1016/j.intimp.2010.11.018.", "ArticleIdList": ["10.1016/j.intimp.2010.11.018", "21109035"]}, {"Citation": "Tang J., Raza A., Chen J., Xu H. A systematic review on the sinomenine derivatives. Mini-Rev. Med. Chem. 2018;18:906\u2013917. doi: 10.2174/1389557517666171123212557.", "ArticleIdList": ["10.2174/1389557517666171123212557", "29173167"]}, {"Citation": "Guo X., Ji J., Feng Z., Hou X., Luo Y., Mei Z. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis. Int. Immunopharmacol. 2020;80:106201. doi: 10.1016/j.intimp.2020.106201.", "ArticleIdList": ["10.1016/j.intimp.2020.106201", "31972421"]}, {"Citation": "Kurko J., Besenyei T., Laki J., Glant T.T., Mikecz K., Szekanecz Z. Genetics of rheumatoid arthritis-A comprehensive review. Clin. Rev. Allergy Immunol. 2013;45:170\u2013179. doi: 10.1007/s12016-012-8346-7.", "ArticleIdList": ["10.1007/s12016-012-8346-7", "PMC3655138", "23288628"]}, {"Citation": "Marquez A., Martin J., Carmona F.D. Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis. Expert Rev. Mol. Diagn. 2016;16:663\u2013675. doi: 10.1080/14737159.2016.1174579.", "ArticleIdList": ["10.1080/14737159.2016.1174579", "27043155"]}, {"Citation": "Hoppe B., Dorner T. Coagulation and the fibrin network in rheumatic disease: A role beyond haemostasis. Nat. Rev. Rheumatol. 2012;8:738\u2013746. doi: 10.1038/nrrheum.2012.184.", "ArticleIdList": ["10.1038/nrrheum.2012.184", "23147903"]}, {"Citation": "Li G.Q., Fang Y.X., Liu Y., Meng F.R., Wu X., Zhang C.W., Zhang Y., Liu D., Gao B. MALAT1-driven inhibition of Wnt signal impedes proliferation and inflammation in fibroblast-Like synoviocytes through CTNNB1 promoter methylation in rheumatoid arthritis. Hum. Gene Ther. 2019;30:1008\u20131022. doi: 10.1089/hum.2018.212.", "ArticleIdList": ["10.1089/hum.2018.212", "30909750"]}, {"Citation": "Chen L., Wang H.J., Ji T.F., Zhang C.J. Chemoproteomics-based target profiling of sinomenine reveals multiple protein regulators of inflammation. Chem. Commun. 2021;57:5981\u20135984. doi: 10.1039/D1CC01522B.", "ArticleIdList": ["10.1039/D1CC01522B", "34027538"]}, {"Citation": "Nathan C. Points of control in inflammation. Nature. 2002;420:846\u2013852. doi: 10.1038/nature01320.", "ArticleIdList": ["10.1038/nature01320", "12490957"]}, {"Citation": "Liu L., Resch K., Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int. J. Immunopharmacol. 1994;16:685\u2013691. doi: 10.1016/0192-0561(94)90142-2.", "ArticleIdList": ["10.1016/0192-0561(94)90142-2", "7989137"]}, {"Citation": "Cheng Y., Zhang J., Hou W., Wang D., Li F., Zhang Y., Yuan F. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int. Immunopharmacol. 2009;9:894\u2013899. doi: 10.1016/j.intimp.2009.03.014.", "ArticleIdList": ["10.1016/j.intimp.2009.03.014", "19336263"]}, {"Citation": "Shu L., Yin W., Zhang J., Tang B., Kang Y.X., Ding F., Hua Z.C. Sinomenine inhibits primary CD4+ T-cell proliferation via apoptosis. Cell Biol. Int. 2007;31:784\u2013789. doi: 10.1016/j.cellbi.2007.01.035.", "ArticleIdList": ["10.1016/j.cellbi.2007.01.035", "17383204"]}, {"Citation": "Chen Y., Yang C., Jin N., Xie Z., Fei L., Jia Z., Wu Y. Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells. Int. Immunopharmacol. 2007;7:1102\u20131110. doi: 10.1016/j.intimp.2007.04.007.", "ArticleIdList": ["10.1016/j.intimp.2007.04.007", "17570327"]}, {"Citation": "Zhao Y., Li J., Yu K., Liu Y., Chen X. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B. Int. Immunopharmacol. 2007;7:637\u2013645. doi: 10.1016/j.intimp.2007.01.007.", "ArticleIdList": ["10.1016/j.intimp.2007.01.007", "17386411"]}, {"Citation": "He X., Wang J., Guo Z., Liu Q., Chen T., Wang X., Cao X. Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol. Lett. 2005;98:91\u201396. doi: 10.1016/j.imlet.2004.10.027.", "ArticleIdList": ["10.1016/j.imlet.2004.10.027", "15790513"]}, {"Citation": "Ou Y.Q., Chen L.H., Li X.J., Lin Z.B., Li W.D. Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147. Acta Pharmacol. Sin. 2009;30:435\u2013441. doi: 10.1038/aps.2009.21.", "ArticleIdList": ["10.1038/aps.2009.21", "PMC4002274", "19305422"]}, {"Citation": "Tong B., Yu J., Wang T., Dou Y., Wu X., Kong L., Dai Y., Xia Y. Sinomenine suppresses collagen-induced arthritis by reciprocal modulation of regulatory T cells and Th17 cells in gut-associated lymphoid tissues. Mol. Immunol. 2015;65:94\u2013103. doi: 10.1016/j.molimm.2015.01.014.", "ArticleIdList": ["10.1016/j.molimm.2015.01.014", "25656802"]}, {"Citation": "Tong B., Yuan X., Dou Y., Wu X., Wang Y., Xia Y., Dai Y. Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor. Lab. Investig. 2016;96:1076\u20131086. doi: 10.1038/labinvest.2016.86.", "ArticleIdList": ["10.1038/labinvest.2016.86", "27617398"]}, {"Citation": "Jegerschold C., Pawelzik S.C., Purhonen P., Bhakat P., Gheorghe K.R., Gyobu N., Mitsuoka K., Morgenstern R., Jakobsson P.J., Hebert H. Structural basis for induced formation of the inflammatory mediator prostaglandin E2. Proc. Natl. Acad. Sci. USA. 2008;105:11110\u201311115. doi: 10.1073/pnas.0802894105.", "ArticleIdList": ["10.1073/pnas.0802894105", "PMC2516235", "18682561"]}, {"Citation": "Zhou H., Liu J.X., Luo J.F., Cheng C.S., Leung E.L., Li Y., Su X.H., Liu Z.Q., Chen T.B., Duan F.G., et al. Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis. Biochem. Pharmacol. 2017;142:133\u2013144. doi: 10.1016/j.bcp.2017.07.010.", "ArticleIdList": ["10.1016/j.bcp.2017.07.010", "28711625"]}, {"Citation": "Luo J.F., Yao Y.D., Cheng C.S., Lio C.K., Liu J.X., Huang Y.F., He F., Xie Y., Liu L., Liu Z.Q., et al. Sinomenine increases the methylation level at specific GCG site in mPGES-1 promoter to facilitate its specific inhibitory effect on mPGES-1. Biochim. Biophys. Acta Gene Regul. Mech. 2022;1865:194813. doi: 10.1016/j.bbagrm.2022.194813.", "ArticleIdList": ["10.1016/j.bbagrm.2022.194813", "35417776"]}, {"Citation": "Liu W., Zhang Y., Zhu W., Ma C., Ruan J., Long H., Wang Y. Sinomenine inhibits the progression of rheumatoid arthritis by regulating the secretion of inflammatory cytokines and monocyte/macrophage subsets. Front. Immunol. 2018;9:2228. doi: 10.3389/fimmu.2018.02228.", "ArticleIdList": ["10.3389/fimmu.2018.02228", "PMC6168735", "30319663"]}, {"Citation": "Yue M., Zhang X., Dou Y., Wei Z., Tao Y., Xia Y., Dai Y. Gut-sourced vasoactive intestinal polypeptide induced by the activation of alpha7 nicotinic acetylcholine receptor substantially contributes to the anti-inflammatory effect of sinomenine in collagen-induced arthritis. Front. Pharmacol. 2018;9:675. doi: 10.3389/fphar.2018.00675.", "ArticleIdList": ["10.3389/fphar.2018.00675", "PMC6028598", "29997506"]}, {"Citation": "Zhi Y.K., Li J., Yi L., Zhu R.L., Luo J.F., Shi Q.P., Bai S.S., Li Y.W., Du Q., Cai J.Z., et al. Sinomenine inhibits macrophage M1 polarization by downregulating alpha7nAChR via a feedback pathway of alpha7nAChR/ERK/Egr-1. Phytomedicine. 2022;100:154050. doi: 10.1016/j.phymed.2022.154050.", "ArticleIdList": ["10.1016/j.phymed.2022.154050", "35397284"]}, {"Citation": "Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007;7:678\u2013689. doi: 10.1038/nri2156.", "ArticleIdList": ["10.1038/nri2156", "17717539"]}, {"Citation": "Gao W.J., Liu J.X., Xie Y., Luo P., Liu Z.Q., Liu L., Zhou H. Suppression of macrophage migration by down-regulating Src/FAK/P130Cas activation contributed to the anti-inflammatory activity of sinomenine. Pharmacol. Res. 2021;167:105513. doi: 10.1016/j.phrs.2021.105513.", "ArticleIdList": ["10.1016/j.phrs.2021.105513", "33617975"]}, {"Citation": "de Punder Y.M., van Riel P.L. Rheumatoid arthritis: Understanding joint damage and physical disability in RA. Nat. Rev. Rheumatol. 2011;7:260\u2013261. doi: 10.1038/nrrheum.2011.49.", "ArticleIdList": ["10.1038/nrrheum.2011.49", "21532640"]}, {"Citation": "Okamoto K., Takayanagi H. Osteoclasts in arthritis and Th17 cell development. Int. Immunopharmacol. 2011;11:543\u2013548. doi: 10.1016/j.intimp.2010.11.010.", "ArticleIdList": ["10.1016/j.intimp.2010.11.010", "21081190"]}, {"Citation": "He L.G., Li X.L., Zeng X.Z., Duan H., Wang S., Lei L.S., Li X.J., Liu S.W. Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation. Acta Pharmacol. Sin. 2014;35:203\u2013210. doi: 10.1038/aps.2013.139.", "ArticleIdList": ["10.1038/aps.2013.139", "PMC4651217", "24362325"]}, {"Citation": "He L., Duan H., Li X., Wang S., Zhang Y., Lei L., Xu J., Liu S., Li X. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis. Eur. J. Pharmacol. 2016;779:66\u201379. doi: 10.1016/j.ejphar.2016.03.014.", "ArticleIdList": ["10.1016/j.ejphar.2016.03.014", "26965104"]}, {"Citation": "Zhou B., Lu X., Tang Z., Liu D., Zhou Y., Zeng P., Xiong H. Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis. Biomed. Pharmacother. 2017;90:835\u2013841. doi: 10.1016/j.biopha.2017.03.084.", "ArticleIdList": ["10.1016/j.biopha.2017.03.084", "28437887"]}, {"Citation": "Wu Z., Ma D., Yang H., Gao J., Zhang G., Xu K., Zhang L. Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes. Int. Immunopharmacol. 2021;93:107392. doi: 10.1016/j.intimp.2021.107392.", "ArticleIdList": ["10.1016/j.intimp.2021.107392", "33529910"]}, {"Citation": "Wang Y., Fang Y., Huang W., Zhou X., Wang M., Zhong B., Peng D. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats. J. Ethnopharmacol. 2005;98:37\u201343. doi: 10.1016/j.jep.2004.12.022.", "ArticleIdList": ["10.1016/j.jep.2004.12.022", "15763362"]}, {"Citation": "Liao K., Su X., Lei K., Liu Z., Lu L., Wu Q., Pan H., Huang Q., Zhao Y., Wang M., et al. Sinomenine protects bone from destruction to ameliorate arthritis via activating p62(Thr269/Ser272)-Keap1-Nrf2 feedback loop. Biomed. Pharmacother. 2021;135:111195. doi: 10.1016/j.biopha.2020.111195.", "ArticleIdList": ["10.1016/j.biopha.2020.111195", "33395605"]}, {"Citation": "Yi L., Lyn Y.J., Peng C., Zhu R.L., Bai S.S., Liu L., Wang P.X., Zhou H., Dong Y. Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating alpha7nAChR expression via ERK/Egr-1 pathway. Int. Immunopharmacol. 2018;56:65\u201370. doi: 10.1016/j.intimp.2018.01.015.", "ArticleIdList": ["10.1016/j.intimp.2018.01.015", "29367088"]}, {"Citation": "Yi L., Ke J., Liu J., Lai H., Lv Y., Peng C., Zhi Y., Du Q., Liu L., Wang P., et al. Sinomenine increases adenosine A2A receptor and inhibits NF-kappaB to inhibit arthritis in adjuvant-induced-arthritis rats and fibroblast-like synoviocytes through alpha7nAChR. J. Leukoc. Biol. 2021;110:1113\u20131120. doi: 10.1002/JLB.3MA0121-024RRRR.", "ArticleIdList": ["10.1002/JLB.3MA0121-024RRRR", "34425026"]}, {"Citation": "Pap T., Korb-Pap A. Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings. Nat. Rev. Rheumatol. 2015;11:606\u2013615. doi: 10.1038/nrrheum.2015.95.", "ArticleIdList": ["10.1038/nrrheum.2015.95", "26195338"]}, {"Citation": "Wang Y., Yu C., Zhang H. Lipopolysaccharides-mediated injury to chondrogenic ATDC5 cells can be relieved by Sinomenine via downregulating microRNA-192. Phytother. Res. 2019;33:1827\u20131836. doi: 10.1002/ptr.6372.", "ArticleIdList": ["10.1002/ptr.6372", "31094031"]}, {"Citation": "Wu Y., Lin Z., Yan Z., Wang Z., Fu X., Yu K. Sinomenine contributes to the inhibition of the inflammatory response and the improvement of osteoarthritis in mouse-cartilage cells by acting on the Nrf2/HO-1 and NF-kappaB signaling pathways. Int. Immunopharmacol. 2019;75:105715. doi: 10.1016/j.intimp.2019.105715.", "ArticleIdList": ["10.1016/j.intimp.2019.105715", "31310911"]}, {"Citation": "Chen L., Zheng L., Chen P., Liang G. Myeloid differentiation primary response protein 88 (MyD88): The central hub of TLR/IL-1R signaling. J. Med. Chem. 2020;63:13316\u201313329. doi: 10.1021/acs.jmedchem.0c00884.", "ArticleIdList": ["10.1021/acs.jmedchem.0c00884", "32931267"]}, {"Citation": "Ramirez-Perez S., Oregon-Romero E., Reyes-Perez I.V., Bhattaram P. Targeting MyD88 downregulates inflammatory mediators and pathogenic processes in PBMC from DMARDs-naive rheumatoid arthritis patients. Front. Pharmacol. 2021;12:800220. doi: 10.3389/fphar.2021.800220.", "ArticleIdList": ["10.3389/fphar.2021.800220", "PMC8735861", "35002734"]}, {"Citation": "Mu H., Yao R.B., Zhao L.J., Shen S.Y., Zhao Z.M., Cai H. Sinomenine decreases MyD88 expression and improves inflammation-induced joint damage progression and symptoms in rat adjuvant-induced arthritis. Inflammation. 2013;36:1136\u20131144. doi: 10.1007/s10753-013-9648-5.", "ArticleIdList": ["10.1007/s10753-013-9648-5", "23605561"]}, {"Citation": "Gao T., Hao J., Wiesenfeld-Hallin Z., Wang D.Q., Xu X.J. Analgesic effect of sinomenine in rodents after inflammation and nerve injury. Eur. J. Pharmacol. 2013;721:5\u201311. doi: 10.1016/j.ejphar.2013.09.062.", "ArticleIdList": ["10.1016/j.ejphar.2013.09.062", "24120369"]}, {"Citation": "Zhu Q., Sun Y., Mao L., Liu C., Jiang B., Zhang W., Li J.X. Antinociceptive effects of sinomenine in a rat model of postoperative pain. Br. J. Pharmacol. 2016;173:1693\u20131702. doi: 10.1111/bph.13470.", "ArticleIdList": ["10.1111/bph.13470", "PMC4842916", "26915970"]}, {"Citation": "Lee J.Y., Yoon S.Y., Won J., Kim H.B., Kang Y., Oh S.B. Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents. Neuroscience. 2017;358:28\u201336. doi: 10.1016/j.neuroscience.2017.06.024.", "ArticleIdList": ["10.1016/j.neuroscience.2017.06.024", "28663089"]}, {"Citation": "Ng J., Coghi P., Law B., Liu L., Wong V. The present and future synthetic strategies of structural modifications of sinomenine. Org. Chem. Front. 2020;7:4089\u20134107. doi: 10.1039/D0QO00785D.", "ArticleIdList": ["10.1039/D0QO00785D"]}, {"Citation": "Wu F.C., Feng X., Wu K.M., Cheng G.F., Huang Y.M., Ye X.R., Qiu P., Zheng X.M. A Series of Sinomenine Derivatives and Their Preparation Methods. CN 101092397. China Patent. 2011 January 19;"}, {"Citation": "Zhao Z., Xiao J., Wang J., Dong W., Peng Z., An D. Anti-inflammatory effects of novel sinomenine derivatives. Int. Immunopharmacol. 2015;29:354\u2013360. doi: 10.1016/j.intimp.2015.10.030.", "ArticleIdList": ["10.1016/j.intimp.2015.10.030", "26525983"]}, {"Citation": "Zhao Z.J., Zhao C., Xiao J., Wang J.C. Transdermal permeation and anti-inflammation activities of novel sinomenine derivatives. Molecules. 2016;21:1520. doi: 10.3390/molecules21111520.", "ArticleIdList": ["10.3390/molecules21111520", "PMC6273864", "27869674"]}, {"Citation": "Jin J., Teng P., Liu H.L., Wu J., Liu Y.M., Xu Q., Li J.X. Microfluidics assisted synthesis and bioevaluation of sinomenine derivatives as antiinflammatory agents. Eur. J. Med. Chem. 2013;62:280\u2013288. doi: 10.1016/j.ejmech.2012.12.051.", "ArticleIdList": ["10.1016/j.ejmech.2012.12.051", "23357309"]}, {"Citation": "Zhou Z., Qiu N., Ou Y., Wei Q., Tang W., Zheng M., Xing Y., Li J.J., Ling Y., Li J., et al. N-Demethylsinomenine, an active metabolite of sinomenine, attenuates chronic neuropathic and inflammatory pain in mice. Sci. Rep. 2021;11:9300. doi: 10.1038/s41598-021-88521-z.", "ArticleIdList": ["10.1038/s41598-021-88521-z", "PMC8085237", "33927244"]}, {"Citation": "Teng P., Liu H.L., Zhang L., Feng L.L., Huai Y., Deng Z.S., Sun Y., Xu Q., Li J.X. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents. Eur. J. Med. Chem. 2012;50:63\u201374. doi: 10.1016/j.ejmech.2012.01.036.", "ArticleIdList": ["10.1016/j.ejmech.2012.01.036", "22325804"]}, {"Citation": "Zhou Y.R., Zhao Y., Bao B.H., Li J.X. SND-117, a sinomenine bivalent alleviates type II collagen-induced arthritis in mice. Int. Immunopharmacol. 2015;26:423\u2013431. doi: 10.1016/j.intimp.2015.04.006.", "ArticleIdList": ["10.1016/j.intimp.2015.04.006", "25887268"]}, {"Citation": "Yan L.C., Bi E.G., Lou Y.T., Wu X.D., Liu Z.D., Zou J., Wang Y., Ma Z., Lin G.M., Sun S.H., et al. Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 2010;391:1093\u20131098. doi: 10.1016/j.bbrc.2009.12.028.", "ArticleIdList": ["10.1016/j.bbrc.2009.12.028", "20004644"]}, {"Citation": "Zhou T.T., Hou J., Wang M., Ma L.Y., Wu L.L., Wang S.Z., Sun B., Yao Z. Regio-controlled synthesis of unsymmetrical pyrazine-fused sinomenine derivatives and discriminate substitution effects on TNF-\u03b1 inhibitory activity. Tetrahedron. 2014;70:5475\u20135482. doi: 10.1016/j.tet.2014.06.112.", "ArticleIdList": ["10.1016/j.tet.2014.06.112"]}, {"Citation": "Ni P., Liu Y., Man J., Li W., Xue S., Lu T., Su Z., Zhou C. C16, a novel sinomenine derivatives, promoted macrophage reprogramming toward M2-like phenotype and protected mice from endotoxemia. Int. J. Immunopath. Ph. 2021;35:1\u20139. doi: 10.1177/20587384211026786.", "ArticleIdList": ["10.1177/20587384211026786", "PMC8256249", "34190613"]}, {"Citation": "Gao F., Dai Z., Zhang T., Gu Y., Cai D., Lu M., Zhang Z., Zeng Q., Shang B., Xu B., et al. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory and analgesic agent. RSC Adv. 2022;12:30001\u201330007. doi: 10.1039/D2RA05558A.", "ArticleIdList": ["10.1039/D2RA05558A", "PMC9582731", "36321084"]}, {"Citation": "Zhang T., Ouyang X., Gou S., Zhang Y., Yan N., Chang L., Li B., Zhang F., Liu H., Ni J. Novel synovial targeting peptide-sinomenine conjugates as a potential strategy for the treatment of rheumatoid arthritis. Int. J. Pharm. 2022;617:121628. doi: 10.1016/j.ijpharm.2022.121628.", "ArticleIdList": ["10.1016/j.ijpharm.2022.121628", "35245636"]}, {"Citation": "Huang L., Dong Y., Wu J., Wang P., Zhou H., Li T., Liu L. Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-kappaB signaling. Pharmacol. Res. 2017;125:150\u2013160. doi: 10.1016/j.phrs.2017.08.014.", "ArticleIdList": ["10.1016/j.phrs.2017.08.014", "28867637"]}, {"Citation": "Gao L.N., Zhong B., Wang Y. Mechanism underlying antitumor effects of sinomenine. Chin. J. Integr. Med. 2019;25:873\u2013878. doi: 10.1007/s11655-019-3151-2.", "ArticleIdList": ["10.1007/s11655-019-3151-2", "30826933"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "7"}, {"Year": "2022", "Month": "11", "Day": "29"}, {"Year": "2022", "Month": "12", "Day": "3"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "48"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["36557779", "PMC9781648", "10.3390/molecules27248645", "molecules27248645"]}}], "PubmedBookArticle": []}